Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer.

Shibahara D, Tanaka K, Togao O, Shiraishi Y, Yoneshima Y, Iwama E, Yoshitake T, Ishigami K, Okamoto I

Open source

DOI
10.1016/j.cllc.2024.06.010
Published
2024 Sep
Container
Clinical lung cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cllc.2024.06.010,
  title = {Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer.},
  author = {Shibahara D and Tanaka K and Togao O and Shiraishi Y and Yoneshima Y and Iwama E and Yoshitake T and Ishigami K and Okamoto I},
  year = {2024},
  journal = {Clinical lung cancer},
  doi = {10.1016/j.cllc.2024.06.010},
  url = {https://doi.org/10.1016/j.cllc.2024.06.010}
}

RIS

TY  - JOUR
TI  - Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer.
AU  - Shibahara D
AU  - Tanaka K
AU  - Togao O
AU  - Shiraishi Y
AU  - Yoneshima Y
AU  - Iwama E
AU  - Yoshitake T
AU  - Ishigami K
AU  - Okamoto I
PY  - 2024
JO  - Clinical lung cancer
DO  - 10.1016/j.cllc.2024.06.010
UR  - https://doi.org/10.1016/j.cllc.2024.06.010
ER  - 

APA

D, S., K, T., O, T., Y, S., Y, Y., E, I., T, Y., K, I., & I, O. (2024). Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer.. Clinical lung cancer. https://doi.org/10.1016/j.cllc.2024.06.010

Source records